Sun Pharmaceutical Industries rises on the BSE
Sun Pharmaceutical Industries is currently trading at Rs. 1722.70, up by 9.30 points or 0.54% from its previous closing of Rs. 1713.40 on the BSE.
The scrip opened at Rs. 1729.95 and has touched a high and low of Rs. 1730.00 and Rs. 1714.00 respectively. So far 24431 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1960.20 on 30-Sep-2024 and a 52 week low of Rs. 1376.75 on 04-Jun-2024.
Last one week high and low of the scrip stood at Rs. 1753.00 and Rs. 1685.00 respectively. The current market cap of the company is Rs. 413993.25 crore.
The promoters holding in the company stood at 54.48%, while Institutions and Non-Institutions held 36.59% and 8.93% respectively.
Sun Pharmaceutical Industries has been included in the S&P Global Sustainability Yearbook 2025. Sun Pharma has qualified in the Top 5% of pharmaceutical companies assessed by S&P globally for this Yearbook.
Within respective industries, this Yearbook aims to distinguish those companies that have demonstrated strengths in corporate sustainability. This recognition attests to Sun Pharma’s commitment to incorporate Environmental, Social, and Governance (ESG) principles through focused initiatives across its businesses.
Based on the S&P Global Corporate Sustainability Assessment (CSA) for 2024, over 7,690 companies globally were assessed for The Sustainability Yearbook 2025. Out of these, 780 companies have qualified for inclusion in The Sustainability Yearbook 2025 globally.
Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.
